Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture

Biomaterials Advances(2022)10.1016/j.bioadv.2022.213009Source: DataRank Database

Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture is a research paper published in Biomaterials Advances (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.50)OA: hybridTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Ying Hu ORCID,Antonina Akk ORCID,Samuel A. Wickline ORCID,Hua Pan ORCID,Christine T. N. Pham ORCID

Live enrichment

PubMed:35891603 PMC:PMC9378586 OpenAlex:https://openalex.org/W4283769401

U.S. Department of Veterans Affairs

Grant: I01 BX005075

NIH

Grant: P30 AR073752

NIH

Grant: R01 HL154009

NHLBI NIH HHS

Grant: R21 HL154009

National Institutes of Health

Grant: 7R21HL154009-02

Prediction and Treatment for Cancer Immunotherapy Induced Myocarditis

National Institutes of Health

Grant: 5P30AR073752-02

Washington University Rheumatic DiseasesResearch Resource-based Center

FWCI

1.50

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.bioadv.2022.213009

publisherhttps://doi.org/10.1016/j.bioadv.2022.213009

publisherhttps://api.elsevier.com/content/article/PII:S2772950822002862?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772950822002862?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35891603

Fields of Study

Aortic aneurysm repair treatmentsInfectious Aortic and Vascular ConditionsAortic Disease and Treatment Approaches0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsPancreatic ElastasePeptidesNF-kappa BAortic Aneurysm, AbdominalRNA, Small InterferingMiceNanoparticles

Keywords

Abdominal aortic aneurysmInflammationCancer researchMedicineGene silencingElastaseNeutrophil extracellular trapsApoptosisPharmacologyCell biologyChemistryImmunologyBiologyAneurysmBiochemistrySurgeryEnzymeNFkappaBNanoparticleSiRNAPancreatic ElastaseICTS (Institute of Clinical and Translational Sciences)NF-kappa B610Small InterferingAortic AneurysmMiceMedicine and Health SciencesRNAAnimalsNanoparticlesAbdominalRNA, Small InterferingPeptidesAortic Aneurysm, Abdominal

Sustainable Development Goals

SDG 0: Good health and well-being

Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture

FAIR Checklist

Authors (6)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)